Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Follitropin alfa
evidence profile

Recombinant human follicle-stimulating hormone glycoprotein. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Follitropin alfa: conceptual scientific illustration for Reproductive Endocrinology
VISUAL GUIDE · Follitropin alfa

Reproductive Endocrinology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

A recombinant human FSH glycoprotein with product-specific infertility indications in women and men. GONAL-f approvals do not make it interchangeable with menotropins, hCG, other follitropins or unverified products, and specialist monitoring remains essential.

01

ENTITY FACTS

What should readers identify first?

MOLECULEFollitropin alfa
PHARMACOLOGYRecombinant human follicle-stimulating hormone glycoprotein
PRIMECORE CLASSA
EVIDENCE GRADEA
RESEARCH TOPICReproductive Endocrinology
LAST REVIEWED2026-08-29

What remains unknown?

Insufficient data in the current dataset

What limits these conclusions?

Insufficient data in the current dataset

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae85b9c3-e7eb-4981-a5d9-346050e8f189
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020378s045%2Cs067%2Cs075lbl.pdf
  3. https://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/pop-up_drug_ex.aspx?Newcode=U1DR1C1062500010311C
  4. https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Follitropin alfa?

Follitropin alfa is described pharmacologically as Recombinant human follicle-stimulating hormone glycoprotein. A recombinant human FSH glycoprotein with product-specific infertility indications in women and men. GONAL-f approvals do not make it interchangeable with menotropins, hCG, other follitropins or unverified products, and specialist monitoring remains essential.

Does Follitropin alfa have strong evidence?

PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Follitropin alfa approved everywhere?

No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice